168 related articles for article (PubMed ID: 33470048)
1. The impact of a prior malignancy on outcomes in gastric cancer patients.
Bian X; Wang K; Wang Q; Yang L; Xia J; Wu W; Li L
Cancer Med; 2021 Feb; 10(4):1457-1470. PubMed ID: 33470048
[TBL] [Abstract][Full Text] [Related]
2. Impact of prior cancer history on survival of patients with gastric cancer.
Wen L; Yu K; Lu H; Zhong G
Eur J Surg Oncol; 2021 Sep; 47(9):2286-2294. PubMed ID: 33632589
[TBL] [Abstract][Full Text] [Related]
3. Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008.
Donin N; Filson C; Drakaki A; Tan HJ; Castillo A; Kwan L; Litwin M; Chamie K
Cancer; 2016 Oct; 122(19):3075-86. PubMed ID: 27377470
[TBL] [Abstract][Full Text] [Related]
4. Prognosis of Hepatocellular Carcinoma Among Cancer Survivors with Other Types of Primary Tumors.
Bian X; He X; Yang L; Wu W; Li L
Dig Dis Sci; 2020 Jul; 65(7):2140-2147. PubMed ID: 31673904
[TBL] [Abstract][Full Text] [Related]
5. Impact of prior malignancy on outcomes of stage IV esophageal carcinoma: SEER based study.
Saad AM; Al-Husseini MJ; Elgebaly A; Aboshady OA; Salahia S; Abdel-Rahman O
Expert Rev Gastroenterol Hepatol; 2018 Apr; 12(4):417-423. PubMed ID: 29316808
[TBL] [Abstract][Full Text] [Related]
6. Impact of a previous cancer history on the overall survival of patients with primary gastric cancer: A SEER population-based study.
Chen Y; Sun R; Liu W
Eur J Surg Oncol; 2022 Oct; 48(10):2159-2165. PubMed ID: 35760621
[TBL] [Abstract][Full Text] [Related]
7. Impact of prior cancer history on the overall survival of patients newly diagnosed with cancer: A pan-cancer analysis of the SEER database.
Zhou H; Huang Y; Qiu Z; Zhao H; Fang W; Yang Y; Zhao Y; Hou X; Ma Y; Hong S; Zhou T; Zhang Y; Zhang L
Int J Cancer; 2018 Oct; 143(7):1569-1577. PubMed ID: 29667174
[TBL] [Abstract][Full Text] [Related]
8. Effect of prior cancer on survival outcomes for patients with advanced prostate cancer.
Wu Y; Chen X; Qian D; Wang W; Zhang Y; Hu J; Zhu J; Wu Q; Cao T
BMC Urol; 2021 Feb; 21(1):26. PubMed ID: 33596896
[TBL] [Abstract][Full Text] [Related]
9. Effect of prior cancer on survival of hepatocellular carcinoma: implications for clinical trial eligibility criteria.
Sun X; Li L; Xu L; Zhou Z; Chen J; Wang J; Zhang Y; Hu D; Chen M
BMC Cancer; 2021 Feb; 21(1):147. PubMed ID: 33563246
[TBL] [Abstract][Full Text] [Related]
10. The Risk of Second Primary Malignancies in Patients With Lung Neuroendocrine Tumors: A Population-Based Study on SEER Database.
Bu X; Wang X; Wei L; Liu J; Chen M
Curr Probl Cancer; 2020 Dec; 44(6):100613. PubMed ID: 32563531
[TBL] [Abstract][Full Text] [Related]
11. Does muscle invasive bladder cancer following pelvic radiotherapy portend worse prognosis? A seer-based study.
Natale C; Leinwand G; Zeineddine F; Silberstein JL; Krane LS
Cancer Treat Res Commun; 2020; 24():100177. PubMed ID: 32454387
[TBL] [Abstract][Full Text] [Related]
12. Risk and survival of second primary malignancies following diagnosis of gastric mucosa-associated lymphoid tissue lymphomas: A population-based study.
Yang Y; Yang Y; Yan S
Curr Probl Cancer; 2021 Dec; 45(6):100735. PubMed ID: 33867153
[TBL] [Abstract][Full Text] [Related]
13. Risk of second primary malignancies associated with radiotherapy in prostate cancer patients: competing risk analysis.
Wu Y; Li Y; Han C; Chong Y; Kang K; Liu Z; Zhang F
Future Oncol; 2022 Feb; 18(4):445-455. PubMed ID: 35018785
[TBL] [Abstract][Full Text] [Related]
14. Prior cancer does not adversely affect survival in locally advanced lung cancer: A national SEER-medicare analysis.
Laccetti AL; Pruitt SL; Xuan L; Halm EA; Gerber DE
Lung Cancer; 2016 Aug; 98():106-113. PubMed ID: 27393515
[TBL] [Abstract][Full Text] [Related]
15. Survival outcomes in esophageal cancer patients with a prior cancer.
Pan D; Xu W; Gao X; Yiyang F; Wei S; Zhu G
Medicine (Baltimore); 2021 Feb; 100(7):e24798. PubMed ID: 33607840
[TBL] [Abstract][Full Text] [Related]
16. Survival of patients newly diagnosed with colorectal cancer and with a history of previous cancer.
Pruitt SL; Gerber DE; Zhu H; Heitjan DF; Maddineni B; Xiong D; Singal AG; Tavakkoli A; Halm EA; Murphy CC
Cancer Med; 2021 Jul; 10(14):4752-4767. PubMed ID: 34190429
[TBL] [Abstract][Full Text] [Related]
17. 20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes:
Milano AF
J Insur Med; 2019; 48(1):5-23. PubMed ID: 31609640
[No Abstract] [Full Text] [Related]
18. Long-term survival among patients with gastrointestinal stromal tumors diagnosed after another malignancy: a SEER population-based study.
Shen C; Wang C; He T; Cai Z; Yin X; Yin Y; Lu D; Zhang B; Zhou Z
World J Surg Oncol; 2020 May; 18(1):88. PubMed ID: 32375797
[TBL] [Abstract][Full Text] [Related]
19. Survival of Patients with First and Metachronous Second Primary Breast Cancer or Lung Cancer Malignancy: Comparisons Using the SEER Database.
Zhong M; He X; Lei K
Adv Ther; 2020 May; 37(5):2236-2245. PubMed ID: 32274747
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological features, risk and survival in lung cancer survivors with therapy-related acute myeloid leukaemia.
Wang H; Yin Y; Wang R; Huang J; Xue H; Cheng Y; Zhang L; Chen C
BMC Cancer; 2020 Nov; 20(1):1081. PubMed ID: 33172389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]